Rewriting the Clinical and Commercial Rulebook with Real-World Data
This webinar explores how real-world data (RWD) and AI are transforming clinical development, evidence generation, and commercialization, particularly in rare diseases and brain cancer. Speakers discuss how integrated RWD helps identify geographically dispersed patients, optimize trial design, support biomarker-driven targeting, and improve commercial strategy, while AI and NLP enable deeper analysis of unstructured clinical data […]
How Real-World Data is Transforming GLP-1 Strategy, and the Keys to Launch Success
This webinar explores how integrated real-world data (RWD) and AI are reshaping commercial strategy for GLP-1 therapies as the obesity and cardiometabolic markets rapidly expand. Speakers discuss how combining EMR, claims, payer, and prescription data helps manufacturers identify untreated patient populations, monitor launches in near real time, understand prescribing and channel trends, and address access […]
Trustworthy and Novel AI in Clinical Trial Planning
This pharmaphorum podcast explores how AI is transforming drug development and commercialization, with Norstella Chief Product Officer Kris Kaneta discussing the growing role of clinical AI powered by robust patient-level data. Kaneta explains how AI can move beyond administrative efficiency to deliver real strategic recommendations for clinical trials, commercialization and decision-making across the product lifecycle. […]
NorstellaLinQ: Identify Obesity Treatment Opportunity Before the Market Does
For GLP-1 therapies, traditional data sources alone aren’t enough to understand the full patient journey. NorstellaLinQ’s 74 billion data points give you the full picture and help you optimize GLP-1 launch strategies in real time. This infographic shows how NorstellaLinQ: Unlocks key information on patients, providers, systems, and payers Uncovers prescribing trends for GLP-1s weeks […]
Using Real-World Data to Redefine Evidence for Ultra-Rare Diseases
In ultra-rare diseases, where traditional control arms are often impractical, regulators still require meaningful context to interpret trial outcomes. Here’s how a biotech company leveraged NorstellaLinQ to build a regulatory-grade real-world control dataset that combined deep unstructured clinical notes, AI-enabled data curation, and rigorous propensity score matching. By creating a highly comparable real-world cohort, the […]
Early Oral GLP-1 Uptake is Half the Story: Who Is Initiating Reveals a Bigger Shift
In the first few weeks following the launch of oral semaglutide, early prescription activity answered a familiar question: Uptake was occurring and growing exponentially within a matter of weeks. But a more consequential signal emerged when looking beyond prescription counts to the patients themselves. After analyzing NorstellaLinQ EMR and open claims data, we found that […]
Deeper Insights, Revealed: Finding Hidden Patient Populations with Unstructured Data
As real-world data (RWD) evolves, the rise of unstructured data—from clinical notes to lab reports—is transforming how life sciences teams identify, understand, and engage with patients and providers. These data sources offer rich, contextual insights into patient experiences, disease progression, and physician decision-making that traditional structured datasets often miss. At a recent industry event, I […]
From Fuel to Firepower: How Real-World Data and AI are Accelerating Pharma
Real-world data (RWD) and Artificial Intelligence (AI) are evolving fast, and with the integration of unstructured data, large language models (LLMs), and multimodal data sources, the next generation of RWD promises deeper, more holistic patient insights than ever before. By combining clinical notes, patient-reported outcomes, and social determinants of health, next-gen RWD can deliver a […]
Revealing Hidden Patient Populations to Optimize Targeting Strategies
A pharmaceutical manufacturer used NorstellaLinQ to uncover hidden patient populations that traditional structured data could not identify. By combining open claims, structured EHR, and unstructured EHR data with advanced data curation, Norstella identified moderate-to-severe atopic dermatitis patients, revealed biologic adoption patterns across healthcare organizations, and delivered actionable insights that improved account targeting, disease-state education, and […]
Norstella’s Real-World Data/AI Executive Forum Highlights
The Norstella Real-World Data Executive Forum explores how real-world data (RWD) can accelerate treatment progress in neuro-oncology, particularly for small patient populations and rare subgroups whose outcomes take years to fully measure. Norstella’s mission to “smooth the path to life-saving therapies” guides its RWD strategy, including curating data elements that closely mirror clinical trial inclusion […]
